Skip to content

Clinical trials

Phase 3 Dry Eye Syndromes trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dry Eye Syndromes Phase: Phase 3 Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20201
20212
20221
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corxel Pharmaceuticals1
Harbour BioMed (Guangzhou) Co. Ltd.1
Jiangsu HengRui Medicine Co., Ltd.1
Lunan Better Pharmaceutical Co., LTD.1
Ocumension Therapeutics (Suzhou) Co., Ltd1
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.1
Shenzhen Hospital of Southern Medical University1
VivaVision Biotech, Inc1
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dry Eye Syndromes9
Meibomian Gland Dysfunction1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.